Uterine (DrugBank: -)
2 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
118 | Myelomeningocele | 1 |
288 | Autoimmune acquired coagulation factor deficiency [Autoimmune Hemorrhaphilia XIII (~Mar 2017)] | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04362592 (ClinicalTrials.gov) | November 2, 2018 | 24/3/2020 | In-Utero Endoscopic Correction of Spina Bifida | In-Utero Endoscopic Correction of Spina Bifida: Laparotomy or Percutaneous | Neural Tube Defects;Spina Bifida;Myelomeningocele | Device: In Utero Endoscopic Correction of Myelomeningocele IDE - Percutaneous Technique;Device: In Utero Endoscopic Correction of Myelomeningocele IDE - Laparotomy/Uterine Exteriorization Technique | University of Southern California | NULL | Recruiting | 18 Years | 52 Years | Female | 33 | N/A | United States |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03871764 (ClinicalTrials.gov) | December 1, 2015 | 8/3/2019 | Prediction of Outcome in Severe Preeclampsia | Relation of 3rd Trimester Uterine Artery Doppler Flow Velocimetry Indices, Factor V Leiden Mutation and Placental Pathology to the Severity of Preeclampsia | Leiden Factor V Deficiency,Preeclampsia;Doppler Examination;Palental Pathology | Diagnostic Test: blood sample , doppler of uterine vessel and placenta | Cairo University | NULL | Completed | N/A | N/A | Female | 100 | NULL |